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1  | INTRODUC TION
Iron deficiency is one of the most common nutrient deficiencies 
worldwide.1 Although the overall prevalence of iron deficiency ane-
mia (IDA) is low in the United States and other developed countries,2 
certain subgroups are at increased risk for iron status disorders. One 
group for whom iron is a particularly critical micronutrient are ath-
letes and recreational exercisers,3 who experience increased iron 
losses through various mechanisms, including excessive sweating, 
gastrointestinal bleeding, hemolysis, and exercise-induced inflam-
mation.4-6 As a result, athletes are almost three times as likely to be 
iron depleted when compared to non-athletes,7 a risk that is even 
further exacerbated in certain groups, such as female adolescent 
athletes, among whom as much as 58% may suffer from iron deple-
tion.7,8 Iron depletion, even in the absence of anemia, can result in 
suboptimal athletic performance,9-11 which can be reversed by means 
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Objectives: Iron depletion is common around the world and among certain risk 
groups in developed countries. The overall purpose was to test the suitability of a 
novel plasma collection card for minimally invasive iron status assessment.
Methods: Twenty participants (10 f/10 m) participated in this cross-sectional study. 
Ferritin and hemoglobin were measured from blood collected from a forearm vein, 
serving as reference method. Blood was also collected from the fingertip using the 
NoviplexTM Plasma Prep Card as well as capillary collection tubes.
Results: There was substantial concordance between ferritin measured from sam-
ples collected via NoviplexTM and venous ferritin (concordance correlation coeffi-
cient (CCC) = 0.96) with a mean bias of −0.8 ng/mL. Storing NoviplexTM cards at room 
temperature for 2 weeks resulted in slightly lower but good concordance when com-
pared to venous ferritin (CCC = 0.95). Capillary hemoglobin (CCC = 0.42) and hema-
tocrit (CCC = 0.25) were in poor agreement with venous data.
Conclusions: NoviplexTM cards offer a suitable alternative for a minimally invasive 
ferritin screening in the field when compared to capillary collection tubes. Despite 
overall substantial concordance with the reference method, findings indicative of 
iron status abnormalities should be confirmed in venous samples.
K E Y W O R D S
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of iron supplementation or dietary intervention.12-16 Considering the 
wide-spread prevalence of iron status abnormalities among athletes 
and its detrimental effects on performance, along with the potential 
dangerous side effects of unmonitored supplementation,6 regular 
screening and monitoring of iron status are common practice among 
athletes.17 The most common screening measure of iron status is 
plasma ferritin, which is reflective of iron storage, along with hemo-
globin and hematocrit reflecting functional iron in red blood cells.11
Routinely, these markers are assessed from blood samples ob-
tained via venous blood sampling. However, venous sampling is in-
vasive, costly, demanding in terms of equipment and requires highly 
trained and certified personnel. When compared to other forms of 
sample collection, it is more likely to result in adverse events for 
subjects and healthcare workers and involves greater sampling 
volumes.18 Further, phlebotomy-related issues are regarded the 
primary source of errors occurring in the pre-analytical phase.19 
An alternative sampling method involves the collection of capillary 
blood, which is considered more applicable in field settings20 and 
has been used for the assessment of iron status markers in various 
vulnerable populations.21-23 In one of the few studies on the validity 
of capillary iron markers, capillary measurements of ferritin were 
found to be ~3%-5% higher and more variable when compared to 
venous blood, although the authors concluded that these issues 
were outweighed by the benefits of using capillary over venous 
blood collection.24
Despite this favorable cost-benefit profile, traditional capillary 
sampling faces challenges similar to venous sampling, such as the 
need to separate plasma from red blood cells, refrigeration, and 
transport under biosafety guidelines. Due to these limitations, nu-
merous attempts have been made to collect blood in the field for 
screening purposes using methods that do not require laborato-
ry-intensive sample preparation and handling.20 The most promis-
ing approach involves blood spots, which have been used by various 
groups to measure ferritin.18,25 These blood spots, which are typi-
cally collected on filter paper and can be stored without freezing, 
reduce burden and cost for sample transport and storage. However, 
blood spots collected on filter paper require precise knowledge of 
the blood volume and extensive sample processing involving incu-
bation with cellulase prior to analysis.18,25 Furthermore, the com-
plete separation of plasma from red blood cells is critical for valid 
assessments of ferritin, as ferritin is present both in plasma and in 
red blood cells, albeit at much higher concentrations in the latter, 
which bears the risk of masking the presence of iron depletion or 
deficiency when cellular ferritin leaks into plasma or whole blood 
is analyzed.20
These challenges can be overcome using a novel plasma col-
lection card, the Noviplex™ Plasma Prep Card (Novilytic, West 
Lafayette, IN). These cards consist of a precut absorbent collection 
disk underneath a membrane filter. Blood can be collected directly 
onto the card test area and exact aliquots of plasma are drawn 
through the filter by capillary action, reducing the likelihood of he-
molysis and removing the need for equipment such as pipettes and 
centrifuges. Given these benefits over more traditional sampling 
methodologies, our overall goal was to test the suitability of these 
cards for minimally invasive assessment of iron status biomarkers. 
The purpose of the present proof-of-concept study was to assess the 
validity of ferritin concentrations in plasma samples collected using 
the NoviplexTM system in comparison with plasma samples obtained 
via venous blood collection, the clinical gold standard. To control for 
potential differences in collection sites, we further assessed iron sta-
tus measures in traditionally collected capillary samples.
2  | METHODS
The present proof-of-concept study was conducted as a cross-sec-
tional comparison of capillary and venous markers of iron status in 
a convenience sample of adults (Figure 1). All procedures were ap-
proved in advance by our university's Institutional Review Board. All 
participants provided written consent prior to data and blood sam-
ple collection.
2.1 | Participants
Participants were recruited locally via word by mouth and fliers. 
Volunteers were included if they were between 19 and 65 years 
of age and non-pregnant. Participants were excluded if they had 
a history of any disease that affects red blood cell morphology or 
felt unable to complete venous and/or capillary blood collection. 
Demographic data and information pertaining to inclusion and ex-
clusion criteria were collected by self-report using a short survey. 
Upon inclusion into the study, height and weight were collected 
using a scale and stadiometer (Seca, Hamburg, Germany).
2.2 | Sample collection
Blood samples were obtained by a trained phlebotomist via veni-
puncture and capillary collection. Venous blood (6 mL) was collected 
Novelty Statement
• We tested a novel methodology for plasma collection 
with regard to its suitability for minimally invasive fer-
ritin assessment.
• Our central finding is that NoviplexTM PLasma Prep 
Cards provide acceptable concordance with the refer-
ence method of venous sampling, even when cards are 
stored for a prolonged time prior to analysis.
• NoviplexTM prep cards are suitable for minimally inva-
sive sample iron status screening, particularly in settings 
outside of the laboratory.
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from an antecubital vein into EDTA-coated tubes (BD Vacutainer®). 
Capillary blood (600 µL) was collected via finger prick using a dispos-
able lancet (SurgiLance™, 2.3 mm depth). The first droplet of blood was 
wiped away, and gentle pressure was applied to collect blood into an 
EDTA-coated capillary tube (Sarstedt Microvette) and directly onto 
the test area of a total of two Noviplex™ Plasma Prep Cards (Novilytic, 
North Webster, IN). For the assessment of ferritin, we used Noviplex™ 
UNO cards, which collect 2.5 µL of plasma onto one collection disk. 
Noviplex™ Plasma Prep Cards have a control indicator which signals 
when sufficient volume of sample has been applied. After 3 minutes, 
the top layer of the card containing the filter used to separate plasma 
from blood cells was removed, and the bottom layer containing the ab-
sorbent collection disk was allowed to dry for 15 minutes prior to fur-
ther analysis. In order to assess the stability of ferritin using Noviplex™ 
cards, one card was processed immediately (immediate analysis), and 
an additional card was stored at room temperature for 14 days prior to 
further processing (delayed analysis).
2.3 | Sample processing
Venous blood samples as well as capillary tubes were centrifuged 
for 10 minutes at 1972 g to separate plasma and red blood cells. 
After centrifugation, plasma was transferred into microcentrifuge 
tubes and stored at −80°C until the time of analysis. For Noviplex™ 
cards, plasma was recovered from the collection disk using 25 µL 
of phosphate-buffered saline (pH 7.4) by agitation for 10 minutes 
using a Gyrotory shaker (New Brunswick Scientific, Edison, NJ). The 
recovered plasma was stored at −80°C until the time of analysis. 
Concentrations were subsequently corrected for the volume differ-
ence in collection and recovery.
2.4 | Assessments
Plasma concentrations of ferritin were determined using commer-
cially available ELISA kits (Ferritin: #S-22; Ramco Laboratories, Inc, 
Houston, TX). ELISAs were performed by the same laboratory tech-
nician as per manufacturer instructions. Venous and capillary sam-
ples collected via capillary tubes were analyzed in duplicate and data 
are reported as the mean of the duplicate analysis. Recovered plasma 
from Noviplex™ Plasma Prep Cards was analyzed in singlet. The limit 
of detection was 0.59 ng/mL and assay precision in our laboratory 
was <8.0% for duplicate samples. For one participant, ferritin data 
are missing for both immediate and delayed analyses of the Plasma 
Prep Card because assay results fell below the limit of detection. For 
another participant, ferritin data are missing only for delayed analysis 
due to a technical error. For venous and capillary blood, we further 
collected whole-blood measurements of hemoglobin (Hb) and hema-
tocrit (Hct), which were taken at the time of draw using a handheld 
AimStrip® Hb Meter (Germaine™ Laboratories, San Antonio, TX). 
As an additional reference, Hb and Hct were also measured using a 
hematology analyzer (QBC Autoread Plus, QBC, Port Matilda, PA), 
although this measurement was conducted on venous samples only.
2.5 | Data analysis and statistics
To assess the validity of Noviplex™ Plasma Prep Cards for ferritin, we 
compared ferritin measured from samples collected with cards to ferri-
tin measured from samples collected via venous blood sampling, which 
served as the reference method. To account for differences in collection 
sites (capillary vs. venous) and collection techniques (cards vs. tubes), we 
further compared ferritin data between samples collected via capillary 
F I G U R E  1   Schematic depiction of the study protocol
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tubes and venous collection and between samples collected via cards 
and capillary tubes. We also compared whole-blood-based markers of 
iron status (hemoglobin and hematocrit) from capillary and venous sam-
ples using a handheld analyzer. To account for possible errors of our 
handheld hematology device, we lastly compared hemoglobin and he-
matocrit data collected using the handheld analyzer with data assessed 
with our laboratory-based hematology analyzer (venous samples only).
Statistical analyses were conducted using R version 3.6.1 (The 
R Foundation for Statistical Computing, 2019). Precision and accu-
racy were determined using the concordance correlation coefficient 
(CCC).26 Concordance was considered perfect for CCC ≥ 0.99, sub-
stantial for 0.95 ≤ CCC <0.99, moderate for 0.90 ≤ CCC <0.95, and 
poor for CCC < 0.90.27 In addition, Bland-Altman analyses were per-
formed to determine mean bias as well as the upper and lower 95% 
limits of agreement (LOA) between two methods, defined as mean 
difference ± 1.96 times the standard deviation.28 To assess the clin-
ical relevance, differences between methods were compared with 
a recommended desirable specification for allowable total error of 
16.9%, as recommended for ferritin.29
3  | RESULTS
3.1 | Participants
Twenty volunteers (10 male and 10 female) between 19 and 56 years 
of age participated in this analysis (Table 1). Average participant age 
and body mass index of our convenience sample were 28.5 ± 8.3 years 
and 26.5 ± 5.3 kg/m2, respectively. The majority of participants were 
white/Caucasian/European (65%), and the remaining participants 
were Asian (10%), Hispanic (10%), Black/African American (5%), and 
mixed race (10%). One male participant had IDA (venous hemo-
globin < 13 g/dL and ferritin < 12 ng/mL). Three female participants 
were considered iron deplete (venous ferritin between 12-25 ng/mL). 
Iron overload, defined as venous ferritin > 200 ng/mL, was evident in 
one male participant. All remaining participants fell within the nor-
mal ranges for hemoglobin and ferritin. Venous hemoglobin concen-
trations were significantly higher in male than in female participants 
(P = .028), as was venous hematocrit (P = .019). Venous ferritin (P = .52) 
was not significantly different between male and female participants.
3.2 | Validity of ferritin measurements
Overall, there was substantial concordance (CCC = 0.96) between 
plasma ferritin measured with NoviplexTM cards and the reference 
standard, ferritin measured from venous blood samples (Figure 2). 
Bland-Altman analysis revealed no systematic bias (mean differ-
ence = −0.8 ng/mL) with upper and lower limits of agreements 
ranging from −23.0 to 21.3 ng/mL. The total error between plasma 
ferritin measured with NoviplexTM cards and venous ferritin ex-
ceeded the recommended desirable range of 16.9% in 8 samples 
(40%). Because the accurate assessment of ferritin near the thresh-
olds for iron depletion (25 ng/mL) and iron deficiency (12 ng/mL) is 
particularly critical, a separate analysis was conducted utilizing only 
data from individuals with a venous ferritin < 75 ng/mL (data not 
shown). While the mean difference remained almost unchanged 
(0.2 ng/mL), the upper and lower limits of agreement narrowed 
(–9.3 to + 9.6 ng/mL).
In order to account for differences in sampling sites, we com-
pared plasma ferritin measured with NoviplexTM cards to ferritin 
measured from capillary blood samples, which showed moderate 
concordance between the two methods (CCC = 0.91) with a mean 
bias of −10.7 ng/mL and limits of agreement ranging from −40.5 to 
19.0 ng/mL. A total of 8 samples (40%) were outside of the recom-
mended desirable range of 16.9% for the total error. The concordance 
between capillary and venous samples was substantial (CCC = 0.96) 
with a mean bias of 9.9 ng/mL and limits of agreement ranging from 
−8.2 to 27.9 ng/mL. The total error between plasma ferritin mea-
sured from capillary and venous samples exceeded 16.9% in 4 sam-
ples (20%). When comparing agreement between duplicate ferritin 
measures (Figure S1), concordance was considered substantial for 
venous (CCC = 0.97) and perfect for capillary (CCC > 0.99) samples.
3.3 | Storage stability
The impact of storing the NoviplexTM card at room temperature for 
2 weeks prior to analysis on capillary ferritin is shown in Figure 3. 
Overall, there was moderate concordance (CCC = 0.94) between 
cards processed immediately and cards stored for 2 weeks. The 
mean bias was 10.5 ng/mL, with limits of agreement ranging from 
−15.4 to 36.5 ng/mL. Concordance between delayed analysis and 
venous ferritin was good (CCC = 0.95) with a mean bias of −6.8 ng/
mL and limits of agreement ranging from −31.1 to 17.5 ng/mL.
3.4 | Impact of collection site on other 
hematological parameters
When assessing the validity of other hematological parameters 
measured from capillary blood, there was poor concordance for 
TA B L E  1   Basic demographic and hematological parameters of our convenience sample (n = 20)
 Age (y) BMI (kg/m2) Hemoglobin (g/dL) Hematocrit (%) Ferritin (ng/mL)
Men 25.6 ± 5.8 26.6 ± 4.1 14.7 ± 1.2 45.7 ± 3.5 85.6 ± 98.2
Women 31.4 ± 9.8 26.4 ± 6.5 13.7 ± 0.4 42.5 ± 1.6 62.9 ± 47.6
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hemoglobin (CCC = 0.42) and hematocrit (CCC = 0.25) when com-
pared to values obtained from venous blood measured with our 
laboratory-based hematology analyzer. Mean biases were 0.25 g/
dL (hemoglobin) and 2.86% (hematocrit) and limits of agreement 
ranged between −0.77 and 1.27 g/dL (hemoglobin) and −0.4 and 
6.2% (hematocrit). Concordance was similarly poor when comparing 
the capillary hemoglobin (CCC = 0.44) and hematocrit (CCC = 0.45) 
with values obtained from venous blood measured with the same 
handheld analyzer. Mean biases were 0.37 g/dL (hemoglobin) 
and 1.0% (hematocrit) and limits of agreement ranged between 
−0.71 and 1.46 g/dL (hemoglobin) and −2.1 and 4.1% (hematocrit). 
Concordance between the handheld analyzer and the hematology 
analyzer using venous samples was improved but remained poor 
for hemoglobin (CCC = 0.87) and hematocrit (CCC = 0.76), as were 
mean biases (hemoglobin: −0.1 g/dL, hematocrit: 1.9%) and limits of 
agreement (hemoglobin: −0.7 to 0.4 g/dL, hematocrit: 0.5 to 3.3%), 
the latter indicating that the handheld device significantly underes-
timated hematocrit.
4  | DISCUSSION
The overall goal of this proof-of-concept study was to evaluate 
whether NoviplexTM Plasma Prep Cards, a novel blood collection 
system, are suitable for minimally invasive screening of iron status. 
Our primary finding was that plasma concentrations of ferritin, when 
assessed from samples collected with the NoviplexTM cards, were in 
overall agreement with plasma ferritin assessed from samples ob-
tained via the gold standard method of venous blood collection, as 
demonstrated by a substantial concordance (CCC = 0.96) and be-
tween the two methods. While there was almost an identical con-
cordance with the reference standard for ferritin measured from 
F I G U R E  2   Left column: Agreement 
between plasma ferritin measured 
from blood samples collected from a 
forearm vein, which served as reference 
standard (venous ferritin), from samples 
collected using the Noviplex™ Plasma 
Prep Cards (Noviplex ferritin), and from 
samples collected via capillary collection 
into a tube (capillary collection). The 
gray lines denote the lines of identity. 
The solid black line depicts the linear 
regression, and dashed lines indicate the 
95% confidence intervals. Right column: 
Bland-Altman analyses of plasma ferritin, 
Noviplex ferritin, and capillary ferritin. 
The dark gray line denotes the line of 
identity. The solid black line depicts the 
mean bias, and dashed lines indicate the 
95% limits of agreement. The gray shaded 
area indicates a desirable allowable total 
error of 16.9% as suggested previously29
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capillary samples (CCC = 0.96), NoviplexTM cards showed virtually 
no mean bias (−0.8 ng/mL), and classic capillary collection demon-
strated a mean bias of 9.9 ng/mL when compared with venous col-
lection. This finding is in agreement with previous findings of slightly 
elevated ferritin concentrations in capillary samples.24 Since he-
molysis is a common risk with capillary sample collection30 and can 
lead to the leaking of ferritin from within red blood cells, where con-
centrations are much higher than in plasma,20 it is possible that the 
slight elevation in ferritin in traditionally collected capillary samples 
is the result of contamination with cell-derived ferritin. With regard 
to sampling sites, it is further important to note that hemoglobin 
and hematocrit values obtained from capillary samples showed only 
poor agreement with those from venous samples. While the validity 
of capillary hemoglobin and hematocrit was not the primary purpose 
of our study, our findings indicate that the collection of samples with 
NoviplexTM card provide certain benefits over traditional capillary 
blood collection into tubes.
The benefits of the NoviplexTM cards, namely the use of a smaller 
sample volume (~40 µL vs. 400 µL) and the eliminated need for pipet-
ting or other equipment (eg, centrifuge, refrigeration), mirror those 
reported for dried blood spots. A recent study by Siart et al (2019) 
assessed the use of dried blood spots for the assessment of inflam-
matory markers in a group of 12 male individuals. And although their 
analysis included a large number of analytes, correlation coefficients 
between venous concentrations and those obtained from dried 
blood spots collected from capillary blood were smaller for all 92 
analytes (< 0.9231) when compared to our results (r = .96).
Another important finding of our study was that samples col-
lected using the NoviplexTM were fairly stable over two weeks of 
storage at room temperature. Ferritin measured from cards stored 
at room temperature for 2 weeks demonstrated good concordance 
when compared both to our reference method of venous samples 
processed immediately (CCC = 0.95) and to NoviplexTM cards ana-
lyzed immediately (CCC = 0.94). These findings are important to con-
sider for the handling of samples, as there is no need for refrigeration. 
Using the NoviplexTM system, samples can be collected on-site and 
subsequently sent to the laboratory for analysis, a procedure which is 
highly advantageous for in-field assessments. When combined with 
the ease of sample collection, the substantially smaller sampling vol-
ume, and a lower risk of bruising and infections, this flexibility opens 
many new avenues for the iron status assessment in many different 
scenarios, such as athletes travelling to remote training and compe-
tition sites. Despite the economic burden of iron status assessments 
in elite athletes,17 wide-spread iron status screening to support an 
athlete's health and performance is strongly advocated in the ath-
letic community.32 Even though there was overall good concordance 
for cards stored at room temperature for 2 weeks, ferritin concen-
trations were slightly reduced, as indicated by mean differences 
of 6.8 ng/mL (when compared to venous samples) and 10.5 ng/mL 
(when compared to card analyzed immediately), a difference which 
should be accounted for when making clinical decisions based solely 
on samples stored for a prolonged period prior to analysis.
Despite the substantial concordance and the virtually non-ex-
istent mean difference between ferritin measured from samples 
F I G U R E  3   Left column: Agreement 
between ferritin measured from blood 
samples collected using the NoviplexTM 
cards analyzed after storing the cards 
for 2 wk at room temperature (delayed 
analysis) with samples collected using the 
NoviplexTM cards which were processed 
immediately (immediate analysis) and with 
ferritin measured from ferritin collected 
from a forearm vein (venous ferritin). 
The gray line denotes the line of identity. 
The solid black line depicts the linear 
regression, and dashed lines indicate 
the 95% confidence intervals. Right 
column: Bland-Altman analyses of delayed 
analysis, immediate analysis, and venous 
ferritin. The gray line denotes the line of 
identity. The solid black line depicts the 
mean bias, and dashed lines indicate the 
95% limits of agreement
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collected via the NoviplexTM system and samples collected via 
venous sampling, it should be noted that 40% of the samples fell 
outside of the previously recommended desirable specification for 
allowable total error of 16.9%.29 It is worth noting that the desir-
able range for the total error was exceeded primarily in samples with 
ferritin concentrations toward the lower end of the concentration 
range, where the allowable error is rather narrow. For samples in 
the range of the cutoffs for IDA (12 ng/mL) and iron depletion (20-
35 ng/mL),33 a total error of 16.9% equates to 2 ng/mL and 3-6 ng/
mL, respectively. If the NoviplexTM system is only used as a screening 
tool, implications of false-positive findings (ie, wrongly identifying a 
person as iron depleted) are minor as long as confirmation analyses 
are conducted via venous sampling. On the other hand, false-neg-
ative findings (ie, failing to identify a person as iron depleted) may 
result in failure to provide dietary intervention or supplementation 
to iron-depleted individuals. Considering these implications, we pro-
pose that individuals whose ferritin measured from plasma collected 
via the NoviplexTM system is <50 ng/mL should undergo follow-up 
assessments. This procedure would ensure that both individuals 
with iron deficiency (ferritin < 12 ng/mL) and those with a high like-
lihood of iron depletion (<20-35 ng/mL) would be identified for fol-
low-up analyses.
It should be noted some variation between ferritin measured 
from samples collected with the NoviplexTM plasma prep cards and 
our reference might be due to analytical error, which we quanti-
fied by comparing duplicate measures for ferritin from venous and 
capillary samples. While there was almost perfect concordance be-
tween duplicate measures for capillary ferritin (CCC > 0.99), the 
concordance for duplicate measures of venous ferritin from the 
same sample (CCC = 0.97) was only slightly higher when compared 
to the concordance of venous and Noviplex ferritin (CCC = 0.96). 
Due to the small sample volume of the NoviplexTM plasma prep 
cards of ~5 µL plasma, we were unable to conduct to measure-
ments in duplicate, an approach which future studies may want to 
pursue in order to minimize the analytical error.
The primary limitations of our study include its relatively small 
sample size of 20 participants, who were recruited from a conve-
nience sample rather than conducting the validation study in ath-
letes or other groups at risk for iron status abnormalities. However, 
given the high prevalence of iron depletion and IDA in these groups, 
the wider range of ferritin concentrations from iron deficiency to 
overload allowed us to test the validity of the NoviplexTM cards 
across the entire ferritin range. Building on the findings of this 
proof-of-concept study, the next step requires a full validation of the 
collection method for ferritin and possibly other biomarkers of iron 
status in a larger sample.
5  | CONCLUSIONS
The findings of this proof-of-concept study suggest that the 
NoviplexTM cards offer a suitable alternative for the evaluation of 
iron status as determined by plasma ferritin when compared to 
capillary blood collection into collection tubes requiring sample pro-
cessing. The benefits of the NoviplexTM cards, which include a small 
sample volume, easy sample processing and handling, the absence 
of expensive equipment (eg, centrifuge and refrigeration), and rela-
tive stability over prolonged storage at room temperature make the 
system suited for minimally invasive iron status screenings in the 
field. Despite substantial concordance with venous blood collec-
tion, abnormal findings indicative of iron status abnormalities should 
be confirmed in venous samples prior to the initiation of dietary or 
pharmacological interventions.
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